DNTH

Latest SEC Filings & News for DNTH

1 most recent filing and news item mentioning DNTH. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/DNTH/news?limit=20"

Pull DNTH filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJun 12, 2026Positive

Dianthus Therapeutics presents autoimmune pipeline advances in June 2026 update

Dianthus Therapeutics released an investor presentation highlighting its autoimmune-focused pipeline, featuring two lead candidates: claseprubart and DNTH212, both in clinical development. The company outlined clinical trial plans and market opportunities for complement therapies

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.